Picture of Philogen SpA logo

PHIL Philogen SpA Cashflow Statement

0.000.00%
it flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Annual cashflow statement for Philogen SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-15.7-5.38-6.1645.3230
Depreciation
Non-Cash Items-0.9564.83-2.17-5.234.5
Other Non-Cash Items
Changes in Working Capital-3.65-7.17-0.133-3.13-1.17
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-18.5-4.94-4.8240.8267
Capital Expenditures-6.82-4.21-5.86-2.41-3.63
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-4128.46.02-19.9-165
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-47.824.20.159-22.3-168
Financing Cash Flow Items0.001
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities63.1-3.78-4.17-3.78-2.99
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3.0815.6-8.814.996.6